Literature DB >> 6692567

Glucosylation of human haemoglobin A. Dynamic variation in HbA1c described by a biokinetic model.

H B Mortensen, A Vølund, C Christophersen.   

Abstract

The reaction kinetics for the reversible condensation of D-glucose and haemoglobin A through a labile haemoglobin A-aldimine adduct to HbA1c have been investigated using a biokinetic model. The specific rate constants obtained from in vitro experiments were included in the model which also took into account the removal of HbA1c by decay of erythrocytes. Using a sinusoidal variation in blood glucose a phase delay of about 2 hours was observed between the maximum blood glucose concentration and the maximum aldimine concentration. The mean haemoglobin A-aldimine concentration was independent of both the amplitude and frequency of the blood glucose oscillations and reached equilibrium concentration within 24 hours. The steady state relation between mean blood glucose and HbA1c was similar to the corresponding relation based on an irreversible formation of HbA1c. However, contrary to the irreversible model the steady state HbA1c concentration with the reversible model was reached 3 to 4 weeks after a change in blood glucose level. This finding is in agreement with clinical experience and indicates that in assessing continuous glycaemic control in diabetic patients haemoglobin A1c should be measured approximately every 3 to 4 weeks.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6692567     DOI: 10.1016/0009-8981(84)90249-3

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

1.  Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoring.

Authors:  Roy Malka; David M Nathan; John M Higgins
Journal:  Sci Transl Med       Date:  2016-10-05       Impact factor: 17.956

2.  A semi-mechanistic model of the relationship between average glucose and HbA1c in healthy and diabetic subjects.

Authors:  Rocío Lledó-García; Norman A Mazer; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-01-10       Impact factor: 2.745

3.  Influence of iron deficiency anemia on hemoglobin A1c levels in diabetic individuals with controlled plasma glucose levels.

Authors:  Alap L Christy; Poornima A Manjrekar; Ruby P Babu; Anupama Hegde; M S Rukmini
Journal:  Iran Biomed J       Date:  2014

4.  Glycated Hemoglobin, Plasma Glucose, and Erythrocyte Aging.

Authors:  Manuel Beltran Del Rio; Mukesh Tiwari; Leo I Amodu; Joaquin Cagliani; Horacio Luis Rodriguez Rilo
Journal:  J Diabetes Sci Technol       Date:  2016-11-01

5.  Longitudinal Modeling of the Relationship Between Mean Plasma Glucose and HbA1c Following Antidiabetic Treatments.

Authors:  J B Møller; R V Overgaard; M C Kjellsson; N R Kristensen; S Klim; S H Ingwersen; M O Karlsson
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-10-30

6.  Prediction of near-future glycated hemoglobin levels using glycated albumin levels before and after treatment for diabetes.

Authors:  Masafumi Koga; Jun Murai; Hiroshi Saito; Soji Kasayama
Journal:  J Diabetes Investig       Date:  2011-08-02       Impact factor: 4.232

7.  Labile A1C is inversely correlated with the hemoglobin glycation index in children with type 1 diabetes.

Authors:  Stuart A Chalew; Robert J McCarter; Jeanine Ory-Ascani; James M Hempe
Journal:  Diabetes Care       Date:  2009-11-16       Impact factor: 19.112

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.